Several studies have reported that CAIX overexpression in breast cancer is a poor prognostic marker for distant metastasis and survival [13, 15, 19, 22, 23], however, in contrast, several other studies did not report a significant association with RFS or OS [14, 24–26]. Here, CA9 is linked to breast cancer.